RNA-seq analysis of liver cancer patients' plasma. RNA-seq analysis of liver cancer patients' plasma

Liver cancer is one of the most lethal cancers worldwide. Liquid biopsy provides a noninvasive approach in detecting and monitoring cancer biomarkers to overcome current limitations associated with tissue biopsies, comprising the analysis of circulating tumor-derived material. In this study, we profiled plasma cell-free RNA-seq to identify recurrently dysregulated RNA biomarkers for the liquid biopsy of cancer. Overall design: RNA-seq of plasma collected from liver cancer patients and healthy donors